Literature DB >> 18319179

Major obstetric hemorrhage.

Frederic J Mercier1, Marc Van de Velde.   

Abstract

Major obstetric hemorrhage remains the leading cause of maternal mortality and morbidity worldwide, and is associated with a high rate of substandard care. A well-defined and multidisciplinary approach that aims to act quickly and avoid omissions or conflicting strategies is key. The most common etiologies of hemorrhage are abruptio placenta, placenta previa/accreta, uterine rupture in the antepartum period and retained placenta, uterine atony, and genital-tract trauma in the postpartum period. Basic treatment of postpartum hemorrhage relies on manual removal of the placenta or manual exploration of the uterus plus bladder emptying and oxytocin administration. If this does not arrest bleeding, or if there is any suspicion of genital-tract trauma, examination of the vagina and cervix with appropriate valves and analgesia/anesthesia must follow quickly. Postpartum uterine atony resistant to oxytocin must be treated with prostaglandin within 15 to 30 minutes; uterine balloon tamponade can be also useful at this stage. Aggressive transfusion therapy and resuscitation are mandatory in major obstetric hemorrhage. Specific invasive treatment must be considered within no more than 30 to 60 minutes, if previous measures have failed -- and even earlier in some particular etiologies. The two main options are radiologic embolization and surgical artery ligations. Recombinant factor VIIa may also be considered, but should not delay the performance of a life-saving procedure such as embolization or surgery. Hysterectomy must be implemented when all other interventions have failed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18319179     DOI: 10.1016/j.anclin.2007.11.008

Source DB:  PubMed          Journal:  Anesthesiol Clin        ISSN: 1932-2275


  16 in total

Review 1.  Autologous blood in obstetrics: where are we going now?

Authors:  Giancarlo Maria Liumbruno; Chiara Liumbruno; Daniela Rafanelli
Journal:  Blood Transfus       Date:  2011-10-25       Impact factor: 3.443

2.  Endovascular management of massive post-partum haemorrhage in abnormal placental implantation deliveries.

Authors:  Alberto Rebonato; Stefano Mosca; Matthias Fischer; Sandro Gerli; Gianluigi Orgera; Luigina Graziosi; Daniele Maiettini; Gian Carlo Di Renzo; Giorgio Epicoco; Miltiadis Krokidis; Michele Rossi; Michele Scialpi
Journal:  Eur Radiol       Date:  2015-09-15       Impact factor: 5.315

3.  Evaluation of "J"-shaped uterine incision during caesarean section in patients with placenta previa: a retrospective study.

Authors:  Li Zou; Shaoping Zhong; Yin Zhao; Jianwen Zhu; Lijuan Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-04-21

4.  Safety and efficacy of tranexamic acid for prevention of obstetric haemorrhage: an updated systematic review and meta-analysis.

Authors:  Massimo Franchini; Carlo Mengoli; Mario Cruciani; Valentino Bergamini; Francesca Presti; Giuseppe Marano; Simonetta Pupella; Stefania Vaglio; Francesca Masiello; Eva Veropalumbo; Vanessa Piccinini; Ilaria Pati; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2018-04-03       Impact factor: 3.443

5.  Placenta percreta and the urologist.

Authors:  Ramdev Konijeti; Jacob Rajfer; Asghar Askari
Journal:  Rev Urol       Date:  2009

6.  Factors associated with peripartum hysterectomy.

Authors:  Clara Bodelon; Antonio Bernabe-Ortiz; Melissa A Schiff; Susan D Reed
Journal:  Obstet Gynecol       Date:  2009-07       Impact factor: 7.661

Review 7.  Endometriosis and Risk of Adverse Pregnancy Outcome: A Systematic Review and Meta-Analysis.

Authors:  Kjerstine Breintoft; Regitze Pinnerup; Tine Brink Henriksen; Dorte Rytter; Niels Uldbjerg; Axel Forman; Linn Håkonsen Arendt
Journal:  J Clin Med       Date:  2021-02-09       Impact factor: 4.241

8.  High-dose tranexamic acid reduces blood loss in postpartum haemorrhage.

Authors:  Anne-Sophie Ducloy-Bouthors; Brigitte Jude; Alain Duhamel; Françoise Broisin; Cyril Huissoud; Hawa Keita-Meyer; Laurent Mandelbrot; Nadia Tillouche; Sylvie Fontaine; Françoise Le Goueff; Sandrine Depret-Mosser; Benoit Vallet; Sophie Susen
Journal:  Crit Care       Date:  2011-04-15       Impact factor: 9.097

9.  Uterine healing after therapeutic intrauterine administration of TachoSil (hemostatic fleece) in cesarean section with postpartum hemorrhage caused by placenta previa.

Authors:  Katrine Fuglsang; Margit Dueholm; Estrid Stæhr-Hansen; Lone Kjeld Petersen
Journal:  J Pregnancy       Date:  2012-04-24

10.  Trends in the rates of peripartum hysterectomy and uterine artery embolization.

Authors:  Geum Joon Cho; Log Young Kim; Hye-Ri Hong; Chang Eun Lee; Soon-Cheol Hong; Min-Jeong Oh; Hai-Joong Kim
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.